Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gastroenterology
•
Obesity Medicine
•
Advanced Endoscopy
In which patients do you recommend endoscopic bariatric procedures (such as endoscopic sleeve gastroplasty) instead of laparoscopic bariatric surgery?
Related Questions
Is there a role for use of GLP1 R agonist or dual agonist therapy for management of post bariatric hypoglycemia and dumping syndrome?
Do you routinely check vitamin K levels in post-bariatric surgery patients?
Can rapid weight loss following GLP1 R agonist therapy lead to postprandial hypoglycemia and if so, what are the treatment options outside of dietary modifications?
How would you manage long-segment Barrett's esophagus with both LGD and HGD that has failed to respond to RFA, cryoablation, or even Nissen fundoplication for large hiatal hernia?
How do you counsel patients on the use of compounded weight loss medications?
Which patients would benefit from pancreatic duct stents in combination with rectal indomethacin for prophylaxis against post-ERCP pancreatitis?
When and how should we be stopping GLP-1 Receptor Agonist/Dual Agonist therapy?
Do you recommend routinely monitoring pancreatic markers such as amylase and lipase while receiving GLP1 R agonist or dual agonist therapies to determine their risk of pancreatitis?
Do you feel there is any difference between performing an ERCP with an EDGE together in a single session or separately in two sessions in a patient with Roux-en-Y anatomy?
What factors influence your choice of EMR vs ESD vs FTR for gastric neoplastic lesions?
